Other
Acute
1
Pipeline Programs↗
11
Active Trials↗
18
Companies Involved↗
Acute is an early-stage landscape with 1 program across 18 companies. The most active players are Eli Lilly, Boehringer Ingelheim, AbbVie.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 21
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
110
clinical trials
Completed68 · 62%
Unknown status17 · 15%
Terminated9 · 8%
Recruiting7 · 6%
Withdrawn5 · 5%
Not yet recruiting2 · 2%
Other2 · 2%
Clinical Trials
Trial Activity
110 trials
Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting
Enrolling by invitation·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT05282706·200 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)